Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 385-401 , December 2009

The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases

  • Alex Iranzo

      Affiliations

    • Corresponding Author InformationCorresponding author. Neurology Service, Hospital Clínic de Barcelona, C/Villarroel 170, Barcelona 08036, Spain. Fax: +34 932275783.
  • ,
  • Joan Santamaria

      Affiliations

    • Present address: Neurology Service, Hospital Clínic de Barcelona, C/Villarroel 170, Barcelona 08036, Spain. Fax: +34 932275783. jsantama@clinic.ub.es.
  • ,
  • Eduard Tolosa

      Affiliations

    • Present address: Neurology Service, Hospital Clínic de Barcelona, Barcelona 08036, Spain. Fax: +34 932275783. etolosa@clinic.ub.es.

References* 

  1. American Academy of Sleep Medicine . The international classification of sleep disorders. 2nd ed.. Westchester, IL: American Academy of Sleep Medicine; 2005;
  2. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25:120–138
  3. Jouvet M, Delrome F. Locus coeruleus et sommeil paradoxal. CR Soc Biol. 1965;159:895–899
  4. Schenckel E, Siegel JM. REM sleep without atonia after lesions of the medial medulla. Neurosci Lett. 1989;98:159–165
  5. Schenck CH, Bundlie SR, Etinger MG, Mahowald MW. Chronical behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9:293–308
  6. Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol. 1992;32:3–10
  7. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology. 1996;46:388–393
  8. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disease: a descriptive study. Lancet Neurol. 2006;5:572–577
  9. Postuma RB, Gagnon JF, Vendette M, Fantini Ml, Massicote- Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2008 (in press).
  10. Plazzi G. REM sleep behavior disorder in Parkinson's disease and other parkinsonian disorders. Sleep Med. 2004;5:195–199
  11. Abad VC, Guilleminault C. Review of rapid eye movement behavior sleep disorders. Curr Neurol Neurosci Rep. 2004;4:157–163
  12. Ferini-Strambi L, Fantini ML, Zucconi M, Castronovo V, Marelli S, Oldani A, et al. REM sleep bevaviour disorder. Neurol Sci. 2005;26(Suppl):186–192
  13. Fantini ML, Ferini-Strambi L, Montplaisir J. Idiopathic REM sleep behavior disorder. Toward a better nosologic definition. Neurology. 2005;64:780–786
  14. Paparrigopoulos TJ. REM sleep behaviour disorder: clinical profiles and pathophysiology. Int Rev Psychiatry. 2005;17:293–300
  15. Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006;67:742–747
  16. Gagnon JF, Postuma RB, Mazza S, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol. 2006;5:424–432
  17. Tachibana N. REM sleep behaviour disorder in Parkinson's disease. J Neurol. 2007;254(Suppl. 4):8–14
  18. Comella CL. REM sleep disorders and parkinsonism. J Neurol. 2007;254(Suppl. 5):56–60
  19. Thomas A, Bonanni L, Onofrj M. Symptomatic REM sleep behaviour disorder. Neurol Sci. 2007;28(Suppl. 1):S21–S36
  20. Gugger JJ, Wagner ML. Rapid eye movement sleep behavior disorder. Ann Pharmacother. 2007;41:1833–1841
  21. Fantini ML, Ferini-Strambi L. Idiopathic rapid eye movement sleep behaviour disorder. Neurol Sci. 2007;28(Suppl. 1):15–20
  22. Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788
  23. Cock VC, Vidailhet M, Arnulf . Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol. 2008;4:254–266
  24. Nadakarni M. Sleep disorders. Cognitive dysfunction in REM sleep behavior disorder. Rev Neurol Dis. 2008;5:162–163
  25. Stores G. Rapid eye movement disorder in children and adolescents. Dev Med Child Neurol. 2008;50:728–732
  26. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry. 1997;20:340–348
  27. Iranzo A, Rye DB, Santamaria J, Valldeoriola F, Marti MJ, Muñoz E, et al. Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD. Neurology. 2005;65:247–252
  28. Manni R, Terzaghi M, Zambelli E. REM sleep behavior disorder and epileptic phenomena: clinical aspects of comorbidity. Epilepsia. 2006;47(Suppl. 5):78–81
  29. Manni R, Terzaghi M, Zambelli E. REM sleep behavior disorder in elderly subjects with epilepsy. Frequency and clinical aspects of the comorbidity. Epilepsy Res. 2007;77:128–133
  30. Iranzo A. The importance of sleep medicine consultation for diagnosis of REM sleep behavior disorder in most patients with Parkinson's disease. Sleep Med. 2002;3:537–538
  31. Schenck CH, Mahowald MW, Kim SW, O'Connor KA, Hurwitz TD. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep. 1992;15:226–235
  32. Winkelman JW, James L. Serotonergic antidepressants are associated with REM sleep without atonia. Sleep. 2004;27(2):317–321
  33. Onofrj M, Luciano AL, Thomas A, Iacono D, D'Andreamatteo G. Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 2003;60:113–115
  34. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000;123:331–339
  35. Schenck CH, Mahowald MW. REM sleep parasomnias. Neurol Clin. 1996;14:697–720
  36. De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, et al. Restoration of normal muscle control in Parkinson's disease during REM sleep. Brain. 2007;130:450–456
  37. Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P, et al. REM sleep behavior disorders in multiple system atrophy. Neurology. 1997;48:1094–1097
  38. Iranzo A, Santamaria J, Vilaseca I, Martinez de Osaba MJ. Absence of alterations in serum sex hormones levels in idiopathic REM sleep behavior disorder. Sleep. 2007;30:803–806
  39. Chou KL, Moro-De-Casillas , Amick MM, Borek LL, Friedman JH. Testosterone not associated with violent dreams or REM sleep behavior disorder in men with Parkinson's. Mov Disord. 2007;22:411–414
  40. Gagnon JF, Bédard MA, Fantini ML, Petit D, Panisset M, Rompré S, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology. 2002;59:585–589
  41. Chiu HFK, Wing YK, Lam LCW, Li SW, Lum CM, Leung T, et al. Sleep-related injury in the elderly. An epidemiological study in Hong Kong. Sleep. 2000;23:513–517
  42. Borek LL, Kohn R, Friedman JH. Phenomenology of dreams in Parkinson's disease. Mov Disord. 2007;22:198–202
  43. Iranzo A, Santamaria J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep. 2005;28:203–206
  44. Constantino AEA, Waters C. Sonambulism in Parkinson's disease: another sleep disorder to deal with. Neurology. 2002;58(Suppl. 3):A432
  45. Poryazova R, Waldvogel D, Bassetti CL. Sleepwalking in patients with parkinsonism. Arch Neurol. 2007;64:1524–1527
  46. Manni R, Terzaghi M. REM behavior disorder associated with epileptic seizures. Neurology. 2005;64:883–884
  47. Bernath O, Guilleminault C. Sleep-related violence, injury, and REM sleep behavior disorder in PD. Neurology. 1999;52:1924
  48. Diedrich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, et al. Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients. Mov Disord. 2005;20:1413–1418
  49. Zhang J, Lam SP, Ho CK. Diagnosis of REM sleep behavior disorder by video-polysomnography study: is one night enough?. Sleep. 2008;31:1179–1185
  50. American Sleep Disorders Association . The international classification of sleep disorders. Diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association; 1990;
  51. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology. 1992;42:1371–1374
  52. Consens F, Chervin RD, Koeppe RA. Validation of a polysomnographic score for REM sleep behavior disorder. Sleep. 2005;28:993–997
  53. Frauscher B, Iranzo A, Höghl B, Casanova-Molla J, Salamero M, Gschliesser V, et al. Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep. 2008;31:724–731
  54. Burns JW, Consens F, Little RJ. EMG variance during polysomnography as an assessment for REM sleep behavior disorder. Sleep. 2007;30:1771–1778
  55. Mayer G, Kesper K, Polch T, Canisius S, Penzel T, Oertel W, et al. Quantification of tonic and phasic muscle activity in REM sleep behavior disorder. J Clin Neurophysiol. 2008;25:48–55
  56. Ferri R, Manconi M, Plazzi G, Vandi S, Poli F, Bruni O, et al. A quantitative statistical analysis of the submental muscle EMG amplitude during sleep in normal controls and patients with REM sleep behavior disorder. J Sleep Res. 2008;17:89–100
  57. Bliwise DR, He L, Ansari FP, Rye DB. Quantification of electromyographic activity during sleep: a phasic electromyographic metric. J Clin Neurophysiol. 2006;23:59–67
  58. Eisensehr I, Linke R, Tatsch K, Kharraz B, Gildehaus JF, Wetter CT, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep. 2003;26:507–512
  59. Sforza E, Krieger J, Petiau C. REM sleep behaviour disorder: clinical and pathophysiological findings. Sleep Med Rev. 1997;1:57–69
  60. Fantini ML, Gagnon JF, Filipini D, Montplaisir J. The effects of pramipexole in REM sleep behavior disorder. Neurology. 2003;61:1418–1420
  61. Frauscher B, Gschliesser V, Brandauer E, Ulmer H, Peralta CM, Müller J, et al. Video analysis of motor events in REM sleep behavior disorder. Mov Disord. 2007;22:1464–1470
  62. Kumru H, Santamaria J, Tolosa E, Valldeoriola F, Muñoz E, Marti MJ, et al. Rapid eye movement disorder in parkinsonism with PARKIN mutations. Ann Neurol. 2004;56:599–603
  63. Dullery C. Colanezapm. In: Dullery C, editor. Therapeutic drugs, vol. 1. Edinburgh: Churchill Livingstone. p. C299–C303.
  64. Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord. 1999;14:507–511
  65. Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurological disorders: results in 14 patients. Sleep Med. 2003;4:281–284
  66. Iranzo A, Santamaría J. Bisoprolol-induced REM sleep behavior disorder. Am J Med. 1999;107:390–392
  67. Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull. 2006;70:386–390
  68. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology. 2006;66:845–851
  69. Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF. Neuropsychological assessment in idiopathic REM sleep behavior disorder. Neurology. 2004;62:41–45
  70. Massicotte-Marquez J, Carrier J, Décary A, Décary A, Mathieu A, Vendette M, et al. Slow-wave sleep and delta power in rapid eye movement sleep behavior disorder. Ann Neurol. 2005;57:277–282
  71. Ferini-Strambi L, Oldani A, Zucconi M, Smirne S. Cardiac autonomic activity during wakefulness and sleep in REM sleep behavior disorder. Sleep. 1996;19:367–369
  72. Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MBIG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–2238
  73. Eisensehr I, Linke R, Noachtar S, Schwarz J, Guildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2000;123:1155–1160
  74. Stockner H, Iranzo A, Seppi K, Serradell M, Gschliesser V, Sojer M, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov disord 2009 (in press).
  75. Unger MM, Möller JC, Stiasny-Kolster K, Mankel K, Berg D, Walter U, et al. Assessment of idiopathic REM sleep behavior disorder by transcranial sonography, olfactory function test and FP-CIT-SPECT. Mov Disord. 2008;23:596–599
  76. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology. 1995;45:709–712
  77. Boeve BF, Dickson DW, Olson EJ, Shepard JW, Silber MH, Ferman TJ, et al. Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med. 2007;8:60–64
  78. Schenck CH, Bundlie SR, Mahowald MW. REM sleep behaviour disorder (RBD) delayed emergence of parkinsonism and/or dementia in 65% of older men initially diagnosed with idiopathic RBD, and an analysis of the maximum and minimum tonic and/or phasic electromyographic abnormalities found during REM sleep. Sleep. 2003;26(Suppl.):A316
  79. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, et al. Sixty-four percent of patients with idiopathic REM sleep behavior disorder developed a neurological disorder after a mean clinical follow-up of seven years. Sleep. 2008;31(Suppl):A280
  80. Wenning GK, Colossi C, Gesser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93–103
  81. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94–98
  82. Benarroch EE. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol. 2003;23:519–526
  83. Tachibana N, Kimura K, Kitajama K, Shinde A, Kimura J, Shibasaki H. REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J Neurol Neurosurg Psychiatry. 1997;63:678–681
  84. Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, et al. Red flags for MSA. Mov Disord. 2008;23:1093–1099
  85. Vetrugno R, Provini F, Cortelli P, Plazzi G, Lotti EM, Pierangeli G, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med. 2004;5:21–30
  86. Gaig C, Iranzo A, Tolosa E, Vilaseca I, Rey MJ, Santamaria J. Pathological description of a non-motor variant of multiple system atrophy. J Neurol Neurosurg Psychiatry. 2008;79:1399–1400
  87. Arnulf I, Mabrouk T, Mohamed K, Konofal E, Derenne JP, Couratier P. Sages 1–2 Non rapid eye movement sleep behavior disorder associated with dementia: anew parasomnia?. Mov Disord. 2005;20:1223–1227
  88. Provini F, Vertugno R, Pastorelli F, Cortelli P, Plazzi G, Lotti EM, et al. Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: a state dependent disorder of motor control during sleep. Mov Disord. 2004;19:719–723
  89. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of mesopontine cholinergic and sparing raphe neurons in multiple system atrophy. Neurology. 2002;59:944–946
  90. Schmeichel AM, Buchalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology. 2008;70:368–373
  91. Iranzo A, Santamaria J, Tolosa E, Vilaseca I, Valldeoriola F, Martí MJ, et al. Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology. 2004;63:930–932
  92. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006;5:75–86
  93. Jellinger KA. Postmortem studies in Parkinson's disease. Is it possible to detect brain areas for specific symptoms?. J Neural Transm. 1999;56(Suppl.):1–29
  94. Wetter TC, Trenkwalder C, Gershanik O, Högl B. Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Wochenschr. 2001;113:249–253
  95. Diederich NJ, Vaillant V, Mancuso G, Lyen P, Tiete J. Progressive sleep destructuring in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Med. 2005;6:313–318
  96. Comella C, Nardine TM, Diederich NJ, Stebbins GT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology. 1998;51:526–529
  97. Antonini A, Pezzoli G, Castronovo V, Giusti MC, Ferini-Strambi L. REM sleep behavior disorder and Parkinson's disease (PD): relationship to PD onset and treatment. Sleep. 2002;25:A494
  98. Scaglione C, Vignatelli L, Plazzi G, Marchese R, Negrotti A, Rizzo G, et al. REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci. 2005;25:316–321
  99. Meral H, Aydemir , Ozer F, Ozturk O, Ozben S, Erol C, et al. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease. Clin Neurol Neurosurg. 2007;109:862–867
  100. Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry. 2007;79:387–391
  101. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008;15:1665–1672
  102. Kumru H, Santamaria J, Tolosa E, Iranzo A. Relation between subtype of Parkinson's disease and REM sleep behavior disorder. Sleep Med. 2007;8:779–783
  103. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. REM sleep behavior disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry. 2008;79:1117–1121
  104. Gagnon JF, Fantini ML, Bédard MA, Petit D, Carrier J, Rompré S, et al. Association between waking EEG slowing and REM sleep behavior in PD without dementia. Neurology. 2004;62:401–406
  105. Vendette M, Gagnon JF, Décary A, Massicotte-Marquez J, Postuma RB, Doyon J, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology. 2007;69:1843–1849
  106. Benninger D, Waldvogel D, Bassetti CL. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia (letter). Neurology. 2008;71:955–956
  107. Comella C, Stevens S, Stepanski E, Leurgans S. Sensitivity analysis of the clinical criteria for REM behavior disorder (RBD) in Parkinson's disease. Neurology. 2002;58(Suppl. 3):A434
  108. Eisensehr I, Lindeiner H, Jäger M, Noachtar S. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography?. J Neurol Sci. 2001;186:7–11
  109. Kumru H, Iranzo A, Carrasco E, Valldeoriola F, Marti MJ, Santamaria J, et al. Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson's disease. Sleep. 2008;31:1418–1421
  110. Arnulf I, Bejjani BP, Garma L, Bonnet AM, Houeto JL, Damier P, et al. Improvement of sleep architecture in PD with subthalamic stimulation. Neurology. 2000;55:1732–1734
  111. Iranzo A, Valldeoriola F, Santamaria J, Tolosa E, Rumia J. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatr. 2002;72:661–664
  112. Mckeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol. 2004;3:19–28
  113. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology. 2005;65:1863–1872
  114. Ferman TJ, Boeve BF. Dementia with Lewy bodies. Neurol Clin. 2007;25:741–760
  115. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689–1707
  116. Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahal K, Aarsland D. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with Lewy bodies and Alzheimer's disease. Mov Disord. 2006;21:337–342
  117. Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, et al. REM sleep behavior disorder and degenerative dementia. An association likely reflecting Lewy body disease. Neurology. 1998;51:363–370
  118. Ferman TJ, Boeve BF, Smith GE, Silber MH, Kokmen E, Petersen RC, et al. REM sleep behavior disorder and dementia. Cognitive differences when compared with AD. Neurology. 1999;52:951–957
  119. Ferman T, Boeve BF, Smith G, Silber MH, Lucas JA, Graff-Radford NR, et al. Dementia with Lewy bodies may present as dementia with REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc. 2002;8:907–914
  120. Boeve BF, Silber MH, Parisi JE. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology. 2003;61:40–45
  121. Boeve BF, Silber MH, Ferman TL. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2004;17:146–157
  122. Boeve BF, Ferman TJ, Silber MH, Smith GE. Sleep disturbances in dementia with Lewy bodies involve more than REM sleep behavior disorder. Neurology. 2003;(Suppl1):A79
  123. Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, et al. DLB fluctuations. Specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–187
  124. Iranzo A, Serradell M, Molinuevo JL, Santamaria J. Neuropsychological profile of mild cognitive impairment in patients with REM sleep behavior disorder. J Sleep Res. 2008;17(Suppl.):103
  125. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  126. Turner RS, D'Amato CJ, Chervin RD, Blaivas M. The pathology of REM sleep behavior disorder with comorbid Lewy body dementia. Neurology. 2000;55:1730–1732
  127. de Brito-Marques PR, de Mello RV, Montenegro L. Nightmares without atonia as an early symptom of diffuse Lewy bodies disease. Arq Neuropsiquiatr. 2003;61:936–941
  128. Gagnon F, Petit F, Fantini ML, Rompré S, Gauthier S, Panisset M, et al. REM sleep behavior and REM sleep without atonia in probable Alzheimer disease. Sleep. 2006;29:1321–1325
  129. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259
  130. Tolosa E, Valldeoriola F, Pastor P. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 152–169
  131. Pareja JA, Caminero AB, Masa JF, Dobato JL, Schenck C. A first case of progressive supranuclear palsy and pre-clinical REM sleep behavior disorder presenting as inhibition of speech during wakefulness and somniloquy with phasic muscle twitching during REM sleep. Neurologia. 1996;11:304–306
  132. Arnulf I, Merino-Andreu M, Bloch F, Konofal E, Vidailhet M, Cochen V, et al. REM sleep behavior disorder and REM sleep without atonia in progressive supranuclear palsy. Sleep. 2005;28:349–354
  133. Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C. Polysomnographic findings, video-based sleep analysis and perception in progressive supranuclear palsy. Sleep Med, in press.
  134. Caparros-Lefebvre D, Sergeant N, Lees A, Camuzat A, Daniel S, Lannuzel A, et al. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like taupathy. Brain. 2002;125:801–811
  135. De Cock VC, Lannuzel A, Verhaeghe S, Verhaeghe S, Roze E, Ruberg M, et al. REM sleep behavior disorder in patients with Guadeloupean parkinsonism, a taupathy. Sleep. 2007;30:1026–1032
  136. Biglan KM, Shoulson I. Huntington's disease. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. Philadelphia: Lippincott Williams & Wilkins; 2007;p. 212–227
  137. Arnulf I, Nielsen J, Lehman E, Schiefer J, Wild E, Jennum P, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;68:482–488
  138. Klockether T. Hereditary ataxias. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. 5th ed.. Philadelphia: Lippincott Williams & Wilkins; 2007;p. 421–435
  139. Friedman JH, Fernandez HH, Sudarsky L. REM behavior disorder and excessive daytime somnolence in Machado–Joseph disease (SCA-3). Mov Disord. 2003;18:1520–1522
  140. Syed BH, Rye DB, Singh G. REM sleep behavior disorder and SCA-3 (Machado–Joseph disease). Neurology. 2003;60:148
  141. Iranzo A, Muñoz E, Santamaria J, Vilaseca I, Mila M, Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado–Joseph disease. Mov Disord. 2003;18:1179–1183
  142. Arnulf I, Merino-Andreu M, Durr A, Camuzant A, Derenne JP, Similowski T. Sleep disorders in autosomic dominant spinocerebellar ataxia: a genotype-phenotype study. Sleep. 2003;26(Suppl.):A353
  143. Boesch S, Frauscher B, Brandauer E, Wenning GK, Höghl B, Poewe W. Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2. Mov Disord. 2006;21:1751–1754
  144. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease nay reflect an underlying synucleionopathy. Mov Disord. 2001;16:622–630
  145. Matheson JK, Saper CB. REM sleep behavior disorder. A dopaminergic deficiency disorder?. Neurology. 2003;61:1328–1329
  146. Jellinger KA. Neuropathological spectrum of synucleinopathies. Mov Disord. 2003;18(Suppl. 6):S2–S12
  147. Turner RS. Idiopathic rapid eye movement sleep behavior disorder is a harbinger of dementia with Lewy bodies. J Geriatr Psychiatry Neurol. 2002;15:195–199
  148. Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BF, Parisi JE. Lewy body variant of Alzheimer's disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry. 1997;42:527–528
  149. Boeve BF, Lin SC, Strongosky A, Dickson DW, Wszolek ZK. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol. 2006;63:268–272
  150. Plazzi G, Cortelli P, Montagna P, De Monte A, Corsini R, Contin M, et al. REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry. 1998;64:683–685
  151. Weyer A, Minnerop M, Abele M, Klockgether T. REM sleep behavioral disorder in pure autonomic failure (PAF). Neurology. 2006;66:608–609
  152. Jellinger KA. Lewy body-related alpha-synucleionopathy in the aged human brain. J Neural Transm. 2004;11:1219–1235
  153. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord. 1996;11:214–216
  154. Schmidt MH, Koshal VB, Schmidt HS. Use of pramipexole in REM sleep behavior disorder: results from a case series. Sleep Med. 2006;7:418–423
  155. Piette T, Mescola P, Uytdenhoef P, Henriet M, Vanderkelen B, Jacquy , et al. A unique episode of RBD was triggered during surgery for Parkinson's disease. J Neurol Sci. 2007;253:73–76
  156. Gilman S, Koeppe RA, Chervin RD, Consens FB, Little R, An H, et al. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology. 2003;61:29–34
  157. García-Borreguero D, Caminero AB, de la Llave Y, Larrosa O, Barrio S, Granizo JJ, et al. Decreased phasic EMG activity during rapad eye movement sleep in treatment-naïve Parkinson's disease: effects of treatment with levodopa and progression of illness. Mov Disord. 2002;17:934–941
  158. Kanyak D, Kiziltan H, Benbir G, Uysal O. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol. 2005;12:199–207
  159. Louden MB, Morehead MA, Schmidt MS. Activation by selegiline of REM sleep behavior in parkinsonism. W V Med J. 1995;91:101
  160. Cicolin A, Lopiano L, Zibetti M, Torre E, Tavella A, Guastamacchia G, et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med. 2004;5:207–210
  161. Kimura K, Tachibana N, Kohyama J, Otsuka Y, Fukuzaka S, Waki R. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology. 2000;55:894–895
  162. Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med. 2002;3:437–439
  163. Zambelis T, Paparrigopoulos T, Soldatos CR. REM sleep behaviour disorder associated with a neurinoma of the left pontocerebellar angle. J Neurol Neurosurg Psychiatry. 2002;72:821–822
  164. Condurso R, Aricò I, Romanello G, Gervasi G, Silvestri R. Status dissociatus in multilacunar encephalopathy with median pontine lesion: a video-polygraphic presentation. J Sleep Res. 2006;15(Suppl. 1):212
  165. Tippmann-Peikert M, Boeve BB, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology. 2006;66:1277–1279
  166. Gomez-Choco M, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of Restless Legs Syndrome and REM Sleep Behavior Disorder in Multiple Sclerosis. Mul Scler. 2007;13:805–808
  167. Xi Z, Luning W. REM sleep behavior disorder in a patient with a pontine stroke. Sleep Med, in press.
  168. Iranzo A, Aparicio J. A lesson from anatomy: focal brain lesions causing REM sleep behavior disorder. Sleep Med, in press.
  169. Tippmann-Peikert M, Boeve BF, Silber MH. Structural lesions associated with REM sleep behavior disorder. Sleep. 2008;31(Suppl.):A264
  170. Boissard R, Fort P, Gervasoni D, Barbagli B, Luppi PH. Localization of the GABAergic and non-GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset. Eur J Neurosci. 2003;18:1627–1639
  171. Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature. 2006;441:589–594
  172. Brooks P, Tse G, Peever J. Impaired gabaergic and glycinergic neurotransmission induces RBD in transgenic mice. Sleep. 2007;30:A11
  173. Burgess C, Lai D, Siegel J, Peever J. An endogenous glutamatergic drive onto somatic motoneurons contributes to the stereotypical pattern of muscle tone across the sleep-wake cycle. J Neurosci. 2008;28:4649–4660
  174. Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, et al. Paradoxical (REM) sleep genesis: The switch from an aminergic-cholinergic to GABAergic-glutamatergic hypothesis. J Physiol Paris. 2007;100:271–283
  175. Chase MH, Soja PJ, Morales FR. Evidence that glycine mediates the postsynaptic potentials that inhibit lumbar motoneurons during the atonia of active sleep. J Neurosci. 1989;9:743–751
  176. Brooks PL, Peever JH. Glycinercic and GABAA-mediated inhibition aof somatic motoneurons does not mediate rapid eye movement sleep mptor atonia. J Neurosci. 2008;28:3535–3545
  177. Funk GD. Are all motoneurons created equal in the eyes of REM sleep and the mechanisms of muscle atonia?. Sleep. 2008;31:1479–1482
  178. Soja PJ. Glycine-mediated postsynaptic inhibition is responsible for REM sleep atonia. Sleep. 2008;31:1483–1486
  179. Chase MH. Confirmation of the consensus that glycinergic postsynaptic inhibition is responsible for the atonia of REM sleep. Sleep; 31:1487–491.
  180. Brooks PL, Peever JH. Unraveling the mechanisms of REM sleep atonia. Sleep. 2008;31:1492–1497
  181. Berger AJ. What causes muscle atonia in REM?. Sleep. 2008;31:1477–1478
  182. Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res. 1982;239:81–105
  183. Zagrodzka J, Hedberg CE, Mann GL, Morrison AR. Contrasting expressions of aggressive behavior related by lesions of the central nucleus of the amygdala during wakefulness and rapid eye movement sleep without atonia in cats. Behav Neurosci. 1998;112:589–602
  184. Iranzo A, Graus F, Clover L. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59:178–182
  185. Lugaresi E, Provini F. Agrypinia excitata: clinical features and pathophysiologic implications. Sleep Med Rev. 2001;5:313–322
  186. Braak H, Rüb U, Sandmann-Keil D, Gai WP, de Vos RA, Jansen Steur EN, et al. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 2000;99:489–495
  187. Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain. 2000;123:1767–1783
  188. Arima K, Murayama S, Mukoyama M, Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. Acta Neuropathol. 1992;83:453–460
  189. Harding AJ, Broe AJ, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain. 2002;125:391–403
  190. Mahowald MW, Schenck MW. Dissociated states of wakefulness and sleep. Neurology. 1992;42(Suppl. 6):44–52
  191. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197–211
  192. Braak H, Rüb U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110:517–536
  193. Kalaitzakis ME, Graeber MB, Gemtelmen SM, Pearce RK. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol. 2008;34:284–295
  194. Jellinger KA. Alpha-synuclein pathology in Parkinson's disease and Alzheimer's disease brain: incidence and topographical distribution-a pilot study. Acta Neuropathol. 2003;106:191–201
  195. Ozawa T, Paviour D, Quinn NP, Ozawa T, Arai T, Hamamatsu A, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127:2657–2671
  196. Parkkinen L, Kauppinen T, Pirttilä , Autere JM, Alafuzoff I. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol. 2005;57:82–91
  197. Lindboe CF, Hansen HB. The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol. 1998;17:2004–2009
  198. Parkkinen L, Soininen H, Laasko M, Alafuzoff . Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol. 2001;27:314–325
  199. Yamamoto R, Iseki E, Marui W, Togo T, Katsuse O, Kato M, et al. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies. Neuropathology. 2005;25:188–194
  200. Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005;20(Suppl. 12):S29–S36

PII: S1087-0792(08)00129-9

doi: 10.1016/j.smrv.2008.11.003

Sleep Medicine Reviews
Volume 13, Issue 6 , Pages 385-401 , December 2009